Anti-Angiogenic Properties of Ginsenoside Rg3 Epimers: In Vitro Assessment of Single and Combination Treatments
Open Access
- 6 May 2021
- Vol. 13 (9), 2223
- https://doi.org/10.3390/cancers13092223
Abstract
Tumour angiogenesis plays a key role in tumour growth and progression. The application of current anti-angiogenic drugs is accompanied by adverse effects and drug resistance. Therefore, finding safer effective treatments is needed. Ginsenoside Rg3 (Rg3) has two epimers, 20(S)-Rg3 (SRg3) and 20(R)-Rg3 (RRg3), with stereoselective activities. Using response surface methodology, we optimised a combination of these two epimers for the loop formation of human umbilical vein endothelial cell (HUVEC). The optimised combination (C3) was tested on HUVEC and two murine endothelial cell lines. C3 significantly inhibited the loop formation, migration, and proliferation of these cells, inducing apoptosis in HUVEC and cell cycle arrest in all of the cell lines tested. Using molecular docking and vascular endothelial growth factor (VEGF) bioassay, we showed that Rg3 has an allosteric modulatory effect on vascular endothelial growth factor receptor 2 (VEGFR2). C3 also decreased the VEGF expression in hypoxic conditions, decreased the expression of aquaporin 1 and affected AKT signaling. The proteins that were mostly affected after C3 treatment were those related to mammalian target of rapamycin (mTOR). Eukaryotic translation initiation factor 4E (eIF4E)-binding protein 1 (4E-BP1) was one of the important targets of C3, which was affected in both hypoxic and normoxic conditions. In conclusion, these results show the potential of C3 as a novel anti-angiogenic drug.Funding Information
- Hospital Research Foundation (Margaret Elcombe)
This publication has 62 references indexed in Scilit:
- RETRACTED ARTICLE: α-santalol inhibits the angiogenesis and growth of human prostate tumor growth by targeting vascular endothelial growth factor receptor 2-mediated AKT/mTOR/P70S6K signaling pathwayMolecular Cancer, 2013
- Use of Allosteric Targets in the Discovery of Safer DrugsMedical Principles and Practice, 2013
- Analysis of colorectal cancers in British Bangladeshi identifies early onset, frequent mucinous histotype and a high prevalence of RBFOX1 deletionMolecular Cancer, 2013
- Stereospecificity of ginsenoside Rg3 in promotion of the immune response to ovalbumin in miceInternational Immunology, 2012
- Translation initiation factors and active sites of protein synthesis co-localize at the leading edge of migrating fibroblastsBiochemical Journal, 2011
- PI3K/AKT/mTOR Pathway in AngiogenesisFrontiers in Molecular Neuroscience, 2011
- GSK-3 inactivation or depletion promotes β-cell replication via down regulation of the CDK inhibitor, p27 (Kip1)Islets, 2011
- Aquaporins and cell migrationPflügers Archiv - European Journal of Physiology, 2007
- Interaction Index and Different Methods for Determining Drug Interaction in Combination TherapyJournal of Biopharmaceutical Statistics, 2007
- Autocrine vascular endothelial growth factor signalling in breast cancer. Evidence from cell lines and primary breast cancer cultures in vitroAngiogenesis, 2005